Tuesday, July 23, 2024

Rogan Gets CNN Pundit to Admit Network Lied About Ivermectin

'When you're convincing yourself of a particular narrative, in this case no vaccine, you find whatever sort of argument you can to support that...'

Popular podcast host Joe Rogan forced CNN’s chief medical correspondent, Sanjay Gupta, to admit that the network falsely claimed Rogan took “horse dewormer” as a COVID-19 treatment.

During a Wednesday episode of “The Joe Rogan Experience,” Rogan pressed the pundit on why he downplayed natural immunity and various treatments to COVID-19.

“By the way,” Gupta replied, “I’m glad you’re better.”

“Thank you. You’re probably the only one at CNN who’s glad … The rest of them are all lying about me taking horse medication,” Rogan said, referring to the network’s coverage of his decision to take Ivermectin as a treatment when he contracted the coronavirus.

“That bothered you,” Gupta said.

“It should bother you too,” Rogan shot back. “They’re lying at your network about people taking human drugs versus drugs for veterinary.”

Gupta then conceded calling ivermectin was “not the most flattering thing.” But Rogan kept pressing.

“It’s a lie,” Rogan pushed back. “It’s a lie on a news network … and it’s a lie that they’re conscious of. It’s not a mistake. They’re unfavorably framing it as veterinary medicine.”

Gupta eventually admitted: “They shouldn’t have done that.”

When asked why CNN chose to frame it that way, Gupta said, “I don’t know.”

Instead of admitting, as Gupta did, that its coverage of ivermectin was intentionally misleading, CNN’s pundits continued to push the same narrative.

CNN’s Don Lemon, for example, denied the network lied about ivermectin, claiming “it is not a lie to say that the drug is used as a horse dewormer.”

Even Gupta went back to bashing Rogan just days after appearing on his podcast. He told CNN’s Erin Burnett that Rogan is “convincing” himself of a “particular narrative.”

Copyright 2024. No part of this site may be reproduced in whole or in part in any manner other than RSS without the permission of the copyright owner. Distribution via RSS is subject to our RSS Terms of Service and is strictly enforced. To inquire about licensing our content, use the contact form at https://headlineusa.com/advertising.
- Advertisement -